Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    12050336 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting e-NOBORI Observational Registry of Nobori DES
Condition: Coronary Artery Disease
Intervention:
2 Unknown  Evaluation of a New Nanotechnology Based Drug-Eluting Stent for Opening of Narrowed Arteries of the Heart
Condition: Coronary Stenosis
Intervention: Device: drug eluting nonpolymeric nanoporous stent
3 Completed Rotational Atherectomy Prior to Taxus Stent
Condition: Complex Calcified Coronary Lesions
Interventions: Procedure: Rotational Atherectomy + PES;   Procedure: Standard Treatment (PES without Rotational Atherectomy)
4 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
5 Completed ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial
Condition: Coronary Occlusions
Intervention: Device: Cypher sirolimus eluting coronary stent
6 Unknown  Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Condition: Coronary Disease
Interventions: Device: 2% rapamycin-eluting YUKONdes PEARL-stent;   Device: 1% rapamycin-eluting YUKONdes PEARL-stent;   Device: YUKONdes PEARL-stent coated with placebo (ethanol)
7 Recruiting French Observatory Evaluating the Use of Intracoronary Prosthesis ABSORB BVS
Condition: Intracoronary Angioplasty
Intervention:
8 Enrolling by invitation NIH Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
Condition: Coronary Restenosis
Intervention:
9 Completed The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
Condition: Coronary Disease
Interventions: Device: Rapamycin-eluting Stent;   Device: Zotarolimus-eluting Stent

Indicates status has not been verified in more than two years